Your browser doesn't support javascript.
loading
Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists.
Umviligihozo, Gisele; Mupfumi, Lucy; Sonela, Nelson; Naicker, Delon; Obuku, Ekwaro A; Koofhethile, Catherine; Mogashoa, Tuelo; Kapaata, Anne; Ombati, Geoffrey; Michelo, Clive M; Makobu, Kimani; Todowede, Olamide; Balinda, Sheila N.
Affiliation
  • Umviligihozo G; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, V5A 1S6, Canada.
  • Mupfumi L; Botswana Harvard AIDS Institute Partnership (BHP), Private Bag BO 320, Bontleng, Gaborone, Botswana.
  • Sonela N; Chantal Biya International Reference Center for research on the management and prevention of HIV/AIDS (CIRCB), Yaoundé, B.P.: 3077, Cameroon.
  • Naicker D; School of Medicine, Physical and Natural Sciences, University of Rome Tor Vegata, Rome, 1-00133, Italy.
  • Obuku EA; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela, School of Medicine, University of KwaZulu-Natal, Durban, 4001, South Africa.
  • Koofhethile C; CoVID Pandemic Rapid Evidence Synthesis Group (CoVPRES), Africa Centre for Systematic Reviews and Knowledge Translation, College of Health Sciences, Makerere University, Kampala, P.O. Box 7072, Uganda.
  • Mogashoa T; Harvard T.H. Chan School of Public Health, Boston, 651 Huntington Ave, Boston, MA, 02115, USA.
  • Kapaata A; Botswana Harvard AIDS Institute Partnership (BHP), Private Bag BO 320, Bontleng, Gaborone, Botswana.
  • Ombati G; International AIDS Vaccine Initiative (IAVI)- Vaccine, Immunology, Science and Technology for Africa (VISTA), Medical Research Council (MRC)/ (Uganda Virus Research Institute) UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, P.O.Box 49, Uganda.
  • Michelo CM; Kenya AIDS Vaccine Initiative-Institute of Clinical Research (KAVI-ICR), College of Health Sciences, University of Nairobi, Nairobi, P.O. Box 19676, Kenya.
  • Makobu K; Rwanda Zambia HIV Research Group (RZHRG), Kigali Rwanda, Lusaka and Ndola, PostNet 412, P/Bag E891, Zambia.
  • Todowede O; Kenya Medical Research Institute (KEMRI), Wellcome Trust Research Program (KWTRP), Kilifi, P.O Box 230, Kenya.
  • Balinda SN; Center for Health Services Studies, University of Kent, Canterbury, CT2 7NF, UK.
Wellcome Open Res ; 5: 163, 2020.
Article in En | MEDLINE | ID: mdl-32984549
Emerging highly transmissible viral infections such as SARS-CoV-2 pose a significant global threat to human health and the economy. Since its first appearance in December 2019 in the city of Wuhan, Hubei province, China, SARS-CoV-2 infection has quickly spread across the globe, with the first case reported on the African continent, in Egypt on February 14 th, 2020. Although the global number of COVID-19 infections has increased exponentially since the beginning of the pandemic, the number of new infections and deaths recorded in African countries have been relatively modest, suggesting slower transmission dynamics of the virus on the continent, a lower case fatality rate, or simply a lack of testing or reliable data. Notably, there is no significant increase in unexplained pneumonias or deaths on the continent which could possibly indicate the effectiveness of interventions introduced by several African governments. However, there has not yet been a comprehensive assessment of sub-Saharan Africa's (SSA) preparedness and response to the COVID-19 pandemic that may have contributed to prevent an uncontrolled outbreak so far. As a group of early career scientists and the next generation of African scientific leaders with experience of working in medical and diverse health research fields in both SSA and resource-rich countries, we present a unique perspective on the current public health interventions to fight COVID-19 in Africa. Our perspective is based on extensive review of the available scientific publications, official technical reports and announcements released by governmental and non-governmental health organizations as well as from our personal experiences as workers on the COVID-19 battlefield in SSA. We documented public health interventions implemented in seven SSA countries including Uganda, Kenya, Rwanda, Cameroon, Zambia, South Africa and Botswana, the existing gaps and the important components of disease control that may strengthen SSA response to future outbreaks.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Wellcome Open Res Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Wellcome Open Res Year: 2020 Document type: Article Affiliation country: Canada Country of publication: United kingdom